|
All pharmaceuticals, total (A00-V20)
|
93,208
|
1,383
|
100
|
81,942
|
1,876
|
100
|
1.28(1.28–1.28)
|
|
Respiratory organs (R* & V01)
|
52,768
|
783
|
56.6
|
45,009
|
1,030
|
54.9
|
1.21(1.21–1.22)
|
|
Coagulation or blood (B*)
|
5,795
|
86
|
6.2
|
6,087
|
139
|
7.4
|
1.49(1.49–1.49)
|
|
Neurology or psychiatry (N03-99)
|
6,515
|
97
|
7.0
|
5,824
|
133
|
7.1
|
1.47(1.47–1.47)
|
|
Pain, muscles, joints (N00-02 & M01-09c)
|
5,358
|
79
|
5.7
|
5,142
|
118
|
6.3
|
1.47(1.47–1.48)
|
|
Diabetes (A10)
|
4,543
|
67
|
4.9
|
3,808
|
87
|
4.6
|
1.32(1.32–1.32)
|
|
Hypertension or heart (C00-09b)
|
4,123
|
61
|
4.4
|
3,523
|
81
|
4.3
|
1.24(1.24–1.24)
|
|
Other digestive system (A00-16d)
|
2,602
|
39
|
2.8
|
2,946
|
67
|
3.6
|
1.64(1.63–1.64)
|
|
Infection (J* & P*)
|
2,178
|
32
|
2.3
|
2,669
|
61
|
3.3
|
1.80(1.79–1.80)
|
|
Thyroid and not-sex hormones (H*)
|
1,299
|
19
|
1.4
|
1,408
|
32
|
1.7
|
1.59(1.58–1.59)
|
|
Urologic disease (G04)
|
1,531
|
23
|
1.6
|
1,048
|
24
|
1.3
|
1.00(0.99–1.00)
|
|
Hyperlipidaemia (C10)
|
1,749
|
26
|
1.9
|
1,028
|
24
|
1.3
|
0.91(0.91–0.91)
|
|
Eyes and ears (S*)
|
1,123
|
17
|
1.2
|
785
|
18
|
1.0
|
0.97(0.97–0.97)
|
|
Gastric acid (A02)
|
716
|
11
|
0.8
|
601
|
14
|
0.7
|
1.26(1.25–1.26)
|
|
Female organs or hormones (G01-03)
|
923
|
14
|
1.0
|
528
|
12
|
0.6
|
0.86(0.85–0.86)
|
|
Dermatology (D*)
|
702
|
10
|
0.8
|
525
|
12
|
0.6
|
1.11(1.11–1.12)
|
|
Osteoporosis (M05)
|
530
|
8
|
0.6
|
514
|
12
|
0.6
|
1.37(1.36–1.38)
|
|
Neoplasms or immune system (L*)
|
309
|
5
|
0.3
|
120
|
3
|
0.1
|
0.59(0.59–0.60)
|
|
Others
|
444
|
7
|
0.5
|
377
|
9
|
0.5
|
1.41(1.40–1.41)
|
